➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Express Scripts
Harvard Business School
Merck
McKinsey

Last Updated: May 6, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LEVOMILNACIPRAN HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Levomilnacipran Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00969150 Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder Completed Forest Laboratories Phase 3 2009-09-01 The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder.
NCT00969709 Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder Completed Forest Laboratories Phase 3 2009-09-01 The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER fixed doses versus placebo in the treatment of outpatients with major depressive disorder.
NCT01034462 Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder Completed Forest Laboratories Phase 3 2009-12-01 The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Levomilnacipran Hydrochloride

Condition Name

Condition Name for Levomilnacipran Hydrochloride
Intervention Trials
Major Depressive Disorder 8
None (i.e. Healthy Volunteers) 1
Major Depressive Disorder (MDD) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Levomilnacipran Hydrochloride
Intervention Trials
Depressive Disorder 10
Depression 10
Depressive Disorder, Major 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Levomilnacipran Hydrochloride

Trials by Country

Trials by Country for Levomilnacipran Hydrochloride
Location Trials
United States 141
Canada 4
Puerto Rico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Levomilnacipran Hydrochloride
Location Trials
Illinois 8
New York 8
California 8
Florida 7
Georgia 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Levomilnacipran Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Levomilnacipran Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 8
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Levomilnacipran Hydrochloride
Clinical Trial Phase Trials
Completed 5
Recruiting 4
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Levomilnacipran Hydrochloride

Sponsor Name

Sponsor Name for Levomilnacipran Hydrochloride
Sponsor Trials
Forest Laboratories 8
Allergan 2
University of Minnesota - Clinical and Translational Science Institute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Levomilnacipran Hydrochloride
Sponsor Trials
Industry 10
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Baxter
Moodys
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.